Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -54.42%7.33B | -1.75%16.08B | 47.77%5.5B | 83.49%4.67B | 60.10%16.37B | 5.55B | 124.83%4.55B | 144.57%3.72B | -3.58%2.54B | 56.59%10.22B |
| Cost of revenue | -57.88%4.96B | -4.94%11.78B | 46.19%4.15B | 73.13%3.47B | 64.07%12.39B | 4.15B | 129.85%3.39B | 157.15%2.84B | 4.63%2.01B | 52.01%7.55B |
| Gross profit | -44.94%2.37B | 8.23%4.3B | 52.85%1.35B | 122.20%1.19B | 48.87%3.98B | 1.39B | 111.31%1.16B | 111.40%884.94M | -25.42%537.45M | 71.19%2.67B |
| Operating expense | 2.18%1.55B | 0.33%1.52B | 7.17%352.86M | 41.25%378.63M | 14.53%1.51B | 549.75M | 12.95%363.61M | 28.58%329.25M | -1.45%268.06M | 12.74%1.32B |
| Operating profit | -70.56%820.45M | 13.07%2.79B | 79.92%999.79M | 202.76%815.61M | 82.39%2.46B | 844.68M | 251.22%795M | 241.91%555.69M | -39.96%269.39M | 246.55%1.35B |
| Net non-operating interest income (expenses) | -353.25%-8.61M | 737.71%3.4M | 469.59%547K | 508.09%959K | 28.55%-533K | -48K | 44.57%-102K | 20.43%-148K | -59.86%-235K | -20.32%-746K |
| Non-operating interest income | 23.66%15.55M | 526.71%12.58M | 307.32%2.11M | 465.44%2.45M | 14.10%2.01M | --536K | 26.03%518K | 19.59%519K | -11.25%434K | -28.12%1.76M |
| Non-operating interest expense | 163.23%24.16M | 261.38%9.18M | 134.93%1.57M | 123.47%1.5M | 1.40%2.54M | --584K | 4.20%620K | 7.58%667K | 5.19%669K | -18.32%2.51M |
| Net investment income | 118.88%12.92M | -179.96%-68.45M | 590.00%4.14M | -1,926.77%-69.05M | 489.82%85.6M | 103.55M | -585.39%-22.33M | -97.15%600K | 145.77%3.78M | 76.77%14.51M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -575.46%-34.91M | 5.10%-5.17M | 0.35%-1.13M | -56.30%-1.77M | -19.93%-5.45M | -2.04M | 0.09%-1.14M | 0.00%-1.14M | 0.00%-1.14M | 9.14%-4.54M |
| Less:Restructuring and mergern&acquisition | --30.31M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Impairment of capital assets | 0.00%4.53M | -0.33%4.53M | -0.35%1.13M | -0.35%1.13M | -0.02%4.54M | --1.14M | -0.09%1.14M | 0.00%1.14M | 0.00%1.14M | -9.14%4.54M |
| Less:Other special charges | --78K | ---- | ---- | ---- | --906K | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | --0 | --643K | --0 | --643K | --0 | ---- | ---- | --0 | --0 | ---- |
| Other non-operating income (expenses) | -25.51%31.45M | -22.22%42.23M | -27.79%15.47M | -37.89%8.72M | -46.63%54.29M | 9.74M | -20.57%9.08M | -23.45%21.43M | -45.13%14.03M | 3.79%101.72M |
| Income before tax | -70.23%821.31M | 6.16%2.76B | 76.75%1.02B | 163.95%754.46M | 77.71%2.6B | 955.88M | 223.77%780.52M | 174.19%576.43M | -39.76%285.84M | 198.10%1.46B |
| Income tax | -71.20%236.43M | 18.84%820.94M | 87.17%349.9M | 180.74%236.39M | 59.18%690.78M | 176.93M | 209.35%242.7M | 203.06%186.94M | -43.70%84.2M | 284.66%433.95M |
| Net income | -69.82%584.88M | 1.57%1.94B | 71.74%668.92M | 156.94%518.07M | 85.53%1.91B | 778.95M | 230.73%537.82M | 162.20%389.49M | -37.95%201.63M | 172.24%1.03B |
| Net income continuous operations | -69.82%584.88M | 1.57%1.94B | 71.74%668.92M | 156.94%518.07M | 85.53%1.91B | --778.95M | 230.73%537.82M | 162.20%389.49M | -37.95%201.63M | 172.24%1.03B |
| Noncontrolling interests | 0 | 0 | 0 | 0 | ||||||
| Net income attributable to the company | -69.82%584.88M | 1.57%1.94B | 71.74%668.92M | 156.94%518.07M | 85.53%1.91B | 778.95M | 230.73%537.82M | 162.20%389.49M | -37.95%201.63M | 172.24%1.03B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -69.82%584.88M | 1.57%1.94B | 71.74%668.92M | 156.94%518.07M | 85.53%1.91B | 778.95M | 230.73%537.82M | 162.20%389.49M | -37.95%201.63M | 172.24%1.03B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -69.81%107.15 | 1.57%354.92 | 71.75%122.51 | 156.92%94.88 | 85.54%349.42 | 142.66 | 230.76%98.5 | 162.24%71.33 | -37.94%36.93 | 172.23%188.33 |
| Diluted earnings per share | -69.81%107.15 | 1.57%354.92 | 71.75%122.5095 | 156.92%94.88 | 85.54%349.42 | 142.66 | 230.75%98.4982 | 162.24%71.33 | -37.94%36.93 | 172.23%188.33 |
| Dividend per share | 0.00%40 | 0.00%40 | 0 | 0 | 33.33%40 | 40 | 0 | 0 | 0 | 200.00%30 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |